Depression and epilepsy, pain and psychogenic non-epileptic seizures: Clinical and therapeutic perspectives

Epilepsy and Behavior

Volumn 24, Issue 2, 2012, Pages 169-181

  Kanner, Andres M ^a   Schachter, Steven C ^a   Barry, John J ^a   Hersdorffer, Dale C ^a   Mula, Marco ^a   Trimble, Michael ^a   Hermann, Bruce ^a   Ettinger, Alan E ^a   Dunn, David ^a   Caplan, Rochelle ^a   Ryvlin, Philippe ^a   Gilliam, Frank ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Major depressive episodes; Pain; Peri ictal depressive episodes; Psychogenic non epileptic seizures; Selective serotonin reuptake inhibitors; Serotonin receptors; Suicidality

Indexed keywords

AMITRIPTYLINE; CITALOPRAM; DOXEPIN; FLUOXETINE; IMIPRAMINE; MIRTAZAPINE; PAROXETINE; REBOXETINE; SERTRALINE;

ANXIETY DISORDER; BECK DEPRESSION INVENTORY; COMORBIDITY; DEPRESSION; EPILEPSY; HUMAN; NEUROLOGIST; PAIN; PSYCHOGENIC NONEPILEPTIC SEIZURE; PSYCHOTHERAPY; QUALITY OF LIFE; REVIEW; SUICIDE;

ADOLESCENT; ADULT; ANTICONVULSANTS; ANXIETY; CHILD; CLINICAL TRIALS AS TOPIC; DEPRESSION; EPILEPSY; HUMANS; MOOD DISORDERS; PAIN; PAIN MANAGEMENT; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SEIZURES; SUICIDAL IDEATION;

EID: 84861372196     PISSN: 15255050     EISSN: 15255069     Source Type: Journal    
DOI: 10.1016/j.yebeh.2012.01.008     Document Type: Review

References (175)

1. Kanner A.M., Kozak A.M., Frey M. The use of sertraline in patients with epilepsy: is it safe?. Epilepsy Behav 2000, 1(2):100-105.
2. Mendez M.F., Cummings J.L., Benson D.F. Depression in epilepsy. Significance and phenomenology. Arch Neurol 1986, 43(8):766-770.
3. Krishnamoorthy E.S., Trimble M.R., Blumer D. The classification of neuropsychiatric disorders in epilepsy: a proposal by the ILAE Commission on Psychobiology of Epilepsy. Epilepsy Behav 2007, 10(3):349-353.
4. Jones J.E., Bell B., Fine J., Rutecki P., Seidenberg M., Hermann B. A controlled prospective investigation of psychiatric comorbidity in temporal lobe epilepsy. Epilepsia 2007, 48(12):2357-2360.
5. Jones J.E., Hermann B.P., Barry J.J., Gilliam F., Kanner A.M., Meador K.J. Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation. J Neuropsychiatry Clin Neurosci Spring 2005, 17(2):172-179.
6. Kraepelin E., Diefendorf A.R. Clinical psychiatry (1907) 1981, Scholars' Facsimiles and Reprints, Delmar, N.Y.
7. Bleuler E. Textbook of psychiatry 1924, The Macmillan Co, New York.
8. Blumer D. Dysphoric disorders and paroxysmal affects: recognition and treatment of epilepsy-related psychiatric disorders. Harv Rev Psychiatry 2000, 8(1):8-17.
9. Mula M., Jauch R., Cavanna A., et al. Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. Epilepsia 2008, 49(4):650-656.
10. Mula M., Jauch R., Cavanna A., et al. Interictal dysphoric disorder and periictal dysphoric symptoms in patients with epilepsy. Epilepsia 2010, 51(7):1139-1145.
11. Tellez-Zenteno J.F., Patten S.B., Jetté N., Williams J., Wiebe S. Psychiatric comorbidity in epilepsy: a population-based analysis. Epilepsia 2007, 48:2336-2344.
12. Kessler R.C., McGonagle K.A., Zhao S., et al. Life-time and 12month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994, 51:8-18.
13. Kessler R., Nelson C., McGonagle K., Liu J., Swartz M., Blazer D. Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey. Br J Psychiatry Suppl 1996, 30:17-30.
14. Coryell W., Endicott J., Andreasen N.C., et al. Depression and panic attacks: the significance of overlap as reflected in follow-up and family study data. Am J Psychiatry Mar 1988, 145(3):293-300.
15. Brown C., Schulberg H.C., Madonia M.J., Shear M.K., Houck P.R. Treatment outcomes for primary care patients with major depression and lifetime anxiety disorders. Am J Psychiatry 1996, 153:1293-1300.
16. Sherbourne C.D., Wells K.B. Course of depression in patients with comorbid anxiety disorders. J Affect Disord 1997, 43(3):245-250.
17. Kanner A.M., Barry J.J., Gilliam F., Hermann B., Meador K.J. Anxiety disorders, sub-syndromic depressive episodes and major depressive episodes: do they differ on their impact on the quality of life of patients with epilepsy?. Epilepsia 2010, 51:1152-1158.
18. Boylan L.S., Flint L.A., Labovitz D.L., Jackson S.C., Starner K., Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004, 62:258-261.
19. Gilliam F., Kuzniecky R., Faught E., et al. Patient-validated content of epilepsy-specific quality-of-life measurement. Epilepsia 1997, 38(2):233-236.
20. Cramer J.A., Blum M., Reed M., Fanning K., Epilepsy Impact Project The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 2003, 4:515-521.
21. Loring D.W., Meador K.J., Lee G.P. Determinants of quality of life in epilepsy. Epilepsy Behav 2004, 5(6):976-980.
22. Perrine K., Hermann B.P., Meador K.J., et al. The relationship of neuropsychological functioning to quality of life in epilepsy. Arch Neurol 1995, 52(10):997-1003.
23. Johnson E.K., Jones J.E., Seidenberg M., Hermann B.P. The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy. Epilepsia 2004, 45(5):544-550.
24. Pfeiffer P.N., Ganoczy D., Ilgen M., Zivin K., Valenstein M. Comorbid anxiety as a suicide risk factor among depressed veterans. Depress Anxiety 2009, 26(8):752-757.
25. Jones J.E., Hermann B.P., Barry J.J., Gilliam F.G., Kanner A.M., Meador K.J. Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy. Epilepsy Behav 2003, 4:S31-S38.
26. Kroenke K., Spitzer R.L., Williams J.B., Monahan P.O., Löwe B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med 2007, 146:317-325.
27. Ettinger A., Reed M., Cramer J. Depression and comorbidity in community-based patients with epilepsy or asthma. Neurology 2004, 63:1008-1014.
28. Ottman R., Lipton R.B., Ettinger A.B., et al. Comorbidities of epilepsy: results from the Epilepsy Comorbidities and Health (EPIC) survey. Epilepsia 2011, 52:308-315.
29. Hesdorffer D.C., Kanner A.M. The FDA alert on suicidality and antiepileptic drugs: fire or false alarm?. Epilepsia 2009, 50:978-986.
30. Barry J.J., Ettinger A.B., Friel P., et al. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. Epilepsy Behav 2008, 13(Suppl 1):S1-29.
31. Placidi G.P., Oquendo M.A., Malone K.M., Brodsky B., Ellis S.P., Mann J.J. Anxiety in major depression: relationship to suicide attempts. Am J Psychiatry 2000, 157:1614-1618.
32. Kanner A.M. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Biol Psychiatry 2003, 54:388-398.
33. Arnau R.C., Meagher M.W., Norris M.P., Bramson R. Psychometric evaluation of the Beck Depression Inventory-II with primary care medical patients. Health Psychol 2001, 20:112-119.
34. Rush A.J., Trivedi M.H., Ibrahim H.M., et al. The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003, 54:573-583.
35. Vahle V.J., Andresen E.M., Hagglund K.J. Depression measures in outcomes research. Arch Phys Med Rehabil 2000, 81:S53-S62.
36. FDA U. Information for healthcare professionals: suicidal behavior and ideation and antiepileptic drugs 2008.
37. Hesdorffer D.C., Berg A.T., Kanner A.M. An update on antiepileptic drugs and suicide: are there definitive answers yet?. Epilepsy Curr 2010, 10:137-145.
38. Mula M., Trimble M.R., Yuen A., Liu R.S., Sander J.W. Psychiatric adverse events during levetiracetam therapy. Neurology 2003, 61:704-706.
39. Mula M., Trimble M.R., Sander J.W. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam. Epilepsia 2007, 48:2322-2326.
40. Hesdorffer D.C., Hauser W.A., Olafsson E., Ludvigsson P., Kjartansson O. Depression and suicide attempt as risk factors for incident unprovoked seizures. Ann Neurol 2006, 59:35-41.
41. Kapur N., Cooper J., King-Hele S., et al. The repetition of suicidal behavior: a multicenter cohort study. J Clin Psychiatry 2006, 67:1599-1609.
42. Arana A., Wentworth C.E., Ayuso-Mateos J.L., Arellano F.M. Suicide-related events in patients treated with antiepileptic drugs. N Engl J Med 2010, 363:542-551.
43. Gibbons R., Hur K., Brown C.H., Mann J.J. Relationship between antiepileptic drugs and suicide attempts in patients with bipolar disorder. Arch Gen Psychiatry 2009, 66:1354-1360.
44. Olesen J.B., Hansen P.R., Erdal J., et al. Antiepileptic drugs and risk of suicide: a nationwide study. Pharmacoepidemiol Drug Saf 2010, 19:518-524.
45. VanCott A.C., Cramer J.A., Copeland L.A., et al. Suicide-related behaviors in older patients with new anti-epileptic drug use: data from the VA hospital system. BMC Med 2010, 8:4.
46. Patorno E., Bohn R.L., Wahl P.M., et al. Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA 2010, 303:1401-1409.
47. Andersohn F., Schade R., Willich S.N., Garbe E. Use of antiepileptic drugs in epilepsy and the risk of self-harm or suicidal behavior. Neurology 2010, 75:335-340.
48. Gibbons R.D., Hur K., Brown C.H., Mann J.J. Gabapentin and suicide attempts. Pharmacoepidemiol Drug Saf 2010, 19:1241-1247.
49. Redden L., Pritchett Y., Robieson W., et al. Suicidality and divalproex sodium: analysis of controlled studies in multiple indications. Arch Gen Psychiatry 2011, 10:1.
50. Barry J., Lembke A., Gisbert P.A., Gilliam F. Affective disorders in epilepsy. Psychiatric issues in epilepsy: a practical guide to diagnosis and treatment 2007, 203-247. Lippincott Williams & Williams, Philadelphia, PA. A.B. Ettinger, A.M. Kanner (Eds.).
51. Kanner A.M., Balabanov A. Depression and epilepsy: how closely related are they?. Neurology 2002, 58(8 Suppl. 5):S27-S39.
52. Boylan L.S., Flint L.A., Labovitz D.L., Jackson S.C., Starner K., Devinsky O. Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy. Neurology 2004, 62(2):258-261.
53. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002, 58(Suppl. 5):S9-S19.
54. Kanner A.M. Depression in epilepsy: a frequently neglected multifaceted disorder. Epilepsy Behav 2003, 4(Suppl. 4):11-19.
55. Wiegartz P., Seidenberg M., Woodard A., Gidal B., Hermann B. Co-morbid psychiatric disorder in chronic epilepsy: recognition and etiology of depression. Neurology 1999, 53(5 Suppl. 2):S3-S8.
56. Robertson M.M. Depression in epilepsy: prevalence, clinical semiology, pathogenic mechanisms, and treatment. Epilepsy: a comprehensive textbook 1997, Lippincott-Raven, Philadelphia. J. Engel, T.A. Pedley (Eds.).
57. Jones J.E., Hermann B.P., Woodard J.L., et al. Screening for major depression in epilepsy with common self-report depression inventories. Epilepsia 2005, 46(5):731-735.
58. Gilliam F., Barry J.J., Hermann B.P., Meador K.J., Vahle V., Kanner A.M. Rapid detection of major depression in epileptics, a multicenter study. Lancet Neurol 2006, 5(5):399-405.
59. Judd L.L., Akiskal H.S., Maser J.D., et al. Major depressive disorder: prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 1998, 50:97-108.
60. Paykel E.S., Ramana R., Cooper Z., Hayhurst H., Kerr J., Barkocka A. Residual symptoms after partial remission: an important outcome in depression. Psychol Med 1995, 25:1171-1180.
61. Havorka J., Herman E., Nemcova I. Treatment of interictal depression with citalopram in patients with epilepsy. Epilepsy Behav 2000, 1:444-447.
62. Specchio L.M., Iudice A., Specchio N., et al. Citalopram as treatment of depression in patients with epilepsy. Clin Neuropharmacol 2004, 27(3):133-136.
63. Kuhn K.U., Quednow B.B., Thiel M., Falkai P., Maier W., Elger C.E. Antidepressive treatment in patients with temporal lobe epilepsy and major depression: a prospective study with three different antidepressants. Epilepsy Behav 2003, 4(6):674-679.
64. Ojemann L.M., Friel P.N., Trejo W.J., et al. Effect of doxepin on seizure frequency in depressed epileptic patients. Neurology 1982, 33:646-648.
65. Robertson M.M., Trimble M.R. The treatment of depression in patients with epilepsy. A double-blind trial. J Affect Disord 1985, 9(2):127-136.
66. Blumer D., Zielenski J.J. Pharmacologic treatment of psychiatric disorders associated with epilepsy. J Epilepsy 1988, 1:135-150.
67. Blumer D. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. J Clin Psychiatry 1997, 58(1):3-11.
68. Keller M.B., McCullough J.P., Klein D.N., et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N Engl J Med 2000, 342:1462-1470.
69. Fava M., Tomba E., Grandi S. The road to recovery from depression-don't drive today with yesterday's map. Psychother Psychosom 2007, 76:260-265.
70. Trivedi M.H., Rush A.J., Wisniewski S.R., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006, 163(1):28-40.
71. Manji H.K., Drevets W.C., Charney D.S. The cellular neurobiology of depression. Nat Med 2001, 7:541-547.
72. Suppes T., Dennehy E.B., Hirschfield R.M.A., et al. The Texas implementation of medication algorithms: update to the algorithms for treatment of bipolar 1 disorders. J Clin Psychiatry 2005, 66:870-886.
73. Schatzberg A.F., Cole J.O., DeBattista C. Augmentation strategies for treatment-resistant disorders. Manual of clinical psychopharmacology 2003, 437-480. American Psychiatric Press, Washington DC.
74. Figiel G.S., McDonald W.M., McCall W.V., et al. Electroconvulsive therapy. Textbook of psychopharmacology 1998, 523-545. American Psychiatric Press, Washington DC. A.F. Schatzberg, C.B. Nemeroff (Eds.).
75. McConnell H., Duncan D. Treatment of psychiatric comorbidity in epilepsy. Psychiatric comorbidity in epilepsy: basic mechanisms, diagnosis, and treatment 1998, 245-362. American Psychiatric Press, Washington DC. H. McConnell, P.J. Snyder (Eds.).
76. George M.S., Rush A.J., Marangell L.B., et al. A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression. Biol Psychiatry 2005, 58(5):364-373.
77. Nahas Z., Marangell L.B., Husain M.M., et al. Two-year outcome of vagus nerve stimulation (VNS) for treatment of major depressive episodes. J Clin Psychiatry 2005, 66:1097-1104.
78. Schachter S.C. Vagus nerve stimulation: mood and cognitive effects. Epilepsy Behav 2004, 5(Suppl. 1):S56-S59.
79. George M.S., Lisanby S.H., Avery D., et al. Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder - a sham-controlled randomized trial. Arch Gen Psychiatry 2010, 67(5):507-516.
80. Cotterman-Hart S. Depression in epilepsy: why aren't we treating?. Epilepsy Behav 2010, 19:419-421.
81. Kanner A.M., Dunn D.W. Diagnosis and management of depression and psychosis in children and adolescents with epilepsy. J Child Neurol 2004, 19(Suppl. 1):S65-S72.
82. Shore C., Austin J., Musick B., et al. Psychosocial care needs of parents of children with new-onset seizures. J Neurosci Nurs 1998, 30:169-174.
83. Goldstein J., Plioplys S., Zelko F., et al. Multidisciplinary approach to childhood epilepsy: exploring the scientific rationale and practical aspects of implementation. J Child Neurol 2004, 19:362-378.
84. Wagner J.L., Smith G. Psychosocial intervention in pediatric epilepsy: a critique of the literature. Epilepsy Behav 2006, 8:39-49.
85. Wohlrab G.C., Rinnert S., Bettendorf U., et al. famoses: a modular educational program for children with epilepsy and their parents. Epilepsy Behav 2007, 10:44-48.
86. Bridge J.A., Iyengar S., Salary C.B., et al. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007, 297:1683-1696.
87. Thomé-Souza M.S., Kuczynski E., Valente K.D. Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression. Epilepsy Behav 2007, 10:417-425.
88. Alper K., Schwartz K.A., Kolts R.L., Khan A. Seizure incidence in psychopharmacological clinical trials: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. Biol Psychiatry 2007, 62:345-354.
89. Ciechanowski P., Chaytor N., Miller J., et al. PEARLS depression treatment for individuals with epilepsy: a randomized controlled trial. Epilepsy Behav 2010, 19:225-231.
90. Martinović Z., Simonović P., Djokić R. Preventing depression in adolescents with epilepsy. Epilepsy Behav 2006, 9:619-624.
91. The Treatment for Adolescents with Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007, 64:1132-1144. The TADS Team.
92. Rodenburg R., Meijer A.M., Deković M., Aldenkamp A.P. Family predictors of psychopathology in children with epilepsy. Epilepsia 2006, 47:601-614.
93. Ferro M.A., Avison W.R., Campbell M.K., Speechley K.N. The impact of maternal depressive symptoms on health-related quality of life in children with epilepsy: a prospective study of family environment as mediators and moderators. Epilepsia 2011, 52:316-325.
94. Ferro M.A., Avison W.R., Campbell M.K., Speechley K.N. Prevalence and trajectories of depressive symptoms in mothers of children with newly diagnosed epilepsy. Epilepsia 2011, 52:326-336.
95. Pilowsky D.J., Wickramaratne P., Talati A., et al. Children of depressed mothers 1year after the initiation of maternal treatment: findings from the STAR*D-Child study. Am J Psychiatry 2008, 165:1136-1147.
96. Hermann B.P., Seidenberg M., Bell B. Psychiatric comorbidity in chronic epilepsy: identification, consequences, and treatment of major depression. Epilepsia 2000, 41(Suppl. 2):S31-S41.
97. Hitiris N., Mohanraj R., Norrie J., Sills G.J., Brodie M.J. Predictors of pharmacoresistant epilepsy. Epilepsy Res 2007, 75:192-196.
98. Mensah S.A., Beavis J.M., Thapar A.K., Kerr M. The presence and clinical implications of depression in a community population of adults with epilepsy. Epilepsy Behav 2006, 8:213-219.
99. Grabowska-Grzyb A., Jedrzejczak J., Nagańska E., Fiszer U. Risk factors for depression in patients with epilepsy. Epilepsy Behav 2006, 8:411-417.
100. Lehrner J., Kalchmayr R., Serles W., et al. Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients. Seizure 1999, 8:88-92.
101. Mendez M.F., Doss R.C., Taylor J.L., Salguero P. Depression in epilepsy. Relationship to seizures and anticonvulsant therapy. J Nerv Ment Dis 1993, 18:444-447.
102. Carreño M., Gil-Nagel A., Sánchez J.C. Strategies to detect adverse effects of antiepileptic drugs in clinical practice. Epilepsy Behav 2008, 13:178-183.
103. Bair M.J., Robinson R.L., Katon W., Kroenke K. Depression and pain comorbidity: a literature review. Arch Intern Med 2003, 163:2433-2445.
104. Mula M., Monaco F. Antiepileptic drugs and psychopathology of epilepsy: an update. Epileptic Disord 2009, 11:1-9.
105. Brodie M.J., Perucca E., Ryvlin P., Ben-Menachem E., Meencke H.-J. Neurology 2007, 68:402-408. for the Levetiracetam Monotherapy Study Group.
106. Marino S.E., Meador K.J., Loring D.W., et al. Subjective perception of cognition is related to mood and not performance. Epilepsy Behav 2009, 14:459-464.
107. Salas-Puig J., Gil-Nagel A., Serratosa J.M., et al. Self-reported memory problems in everyday activities in patients with epilepsy treated with antiepileptic drugs. Epilepsy Behav 2009, 14:622-627.
108. Marazziti D., Consoli G., Picchetti M., Carlini M., Faravelli L. Cognitive impairment in major depression. Eur J Pharmacol 2010, 626:83-86.
109. Mula M., Trimble M.R. Antiepileptic drug-induced cognitive adverse effects. Potential mechanisms and contributing factors. CNS Drugs 2009, 23:121-137.
110. Crocco E.A., Castro K., Loewenstein D.A. How late-life depression affects cognition: neural mechanisms. Curr Psychiatry Rep 2010, 12:34-38.
111. Hixson J.D., Kirsch H.E. The effects of epilepsy and its treatments on affect and emotion. Neurocase 2009, 15:206-216.
112. Kanner A.M., Wuu J., Faught E., et al. A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events. Epilepsy Behav 2003, 4:548-552.
113. Silver J.M., McAllister T.W., Arciniegas D.B. Depression and cognitive complaints following mild traumatic brain injury. Am J Psychiatry 2009, 166:653-661.
114. Cramer J.A., Blum D., Reed M., Fanning K. The influence of comorbid depression on seizure severity. Epilepsia 2003, 44:1578-1584. Epilepsy Impact Project Group.
115. Verdu B., Decosterd I., Buclin T., Stiefel F., Berney A. Antidepressants for the treatment of chronic pain. Drugs 2008, 68:2611-2632.
116. Maletic V., Raison C.L. Neurobiology of depression, fibromyalgia and neuropathic pain. Front Biosci 2009, 14:5291-5338.
117. Von Korff M., Dworkin S.F., Le Resche L., Kruger A. An epidemiologic comparison of pain complaints. Pain 1988, 32:173-183.
118. Leino P., Magni G. Depressive and distress symptoms as predictors of low back pain, neck-shoulder pain, and other musculoskeletal morbidity: a 10-year follow-up of metal industry employees. Pain 1993, 53:89-94.
119. Rief W., Hennings A., Riemer S., Euteneuer F. Psychobiological differences between depression and somatization. J Psychosom Res 2010, 68:495-502.
120. Gambassi G. Pain and depression: the egg and the chicken story revisited. Arch Gerontol Geriatr 2009, 49(Suppl. 1):103-112.
121. Finocchi C., Villani V., Casucci G. Therapeutic strategies in migraine patients with mood and anxiety disorders: clinical evidence. Neurol Sci 2010, 31(Suppl. 1):S95-S98.
122. Nampiaparampil D.E. Prevalence of chronic pain after traumatic brain injury. JAMA 2008, 300:711-719.
123. Lépine J.P., Briley M. The epidemiology of pain in depression. Hum Psychopharmacol 2004, 19(Suppl. 1):S3-S7.
124. Dworkin R.H., Gitlin M.J. Clinical aspects of depression in chronic pain. Clin J Pain 1991, 7:79-94.
125. Kerns R.D., Haythornthwaite J.A. Depression among chronic pain patients: cognitive-behavioral analysis and effect on rehabilitation outcome. J Consult Clin Psychol 1988, 56:870-876.
126. Painter J.R., Seres J.L., Newman R.I. Assessing benefits of the pain center: why some patients regress. Pain 1980, 8:101-113.
127. Bowman E.S., Markand O.N. Psychodynamics and psychiatric diagnoses of pseudoseizure subjects. Am J Psychiatry 1996, 153(1):57-63.
128. Devinsky O., Gazzola D., LaFrance W.C. Differentiating between nonepileptic and epileptic seizures. Nat Rev Neurol 2011, 7:210-220.
129. LaFrance W.C., Barry J.J. Update on treatments of psychological nonepileptic seizures. Epilepsy Behav 2005, 7(3):364-374.
130. Baslet G. Psychogenic non-epileptic seizures: a model of their pathogenic mechanism. Seizure 2011, 20(1):1-13.
131. LaFrance W.C. Psychogenic nonepileptic seizures. Curr Opin Neurol 2008, 21(2):195-201.
132. Snyder S.L., Rosenbaum D.H., Rowan A.J., Strain J.J. SCID diagnosis of panic disorder in psychogenic seizure patients. J Neuropsychiatry Clin Neurosci 1994, 6(3):261-266.
133. Kanner A.M., Parra J., Frey M., Stebbins G., Pierre-Louis S., Iriarte J. Psychiatric and neurologic predictors of psychogenic pseudoseizure outcome. Neurology 1999, 53(5):933-938.
134. Mökleby K., Blomhoff S., Malt U.F., Dahlström A., Tauböll E., Gjerstad L. Psychiatric comorbidity and hostility in patients with psychogenic nonepileptic seizures compared with somatoform disorders and healthy controls. Epilepsia 2002, 43(2):193-198.
135. Kuyk J., Swinkels W.A., Spinhoven P. Psychopathologies in patients with nonepileptic seizures with and without comorbid epilepsy: how different are they?. Epilepsy Behav 2003, 4(1):13-18.
136. Baillès E., Pintor L., Fernandez-Egea E., et al. Psychiatric disorders, trauma, and MMPI profile in a Spanish sample of nonepileptic seizure patients. Gen Hosp Psychiatry 2004, 26(4):310-315.
137. D'Alessio L., Giagante B., Oddo S., et al. Psychiatric disorders in patients with psychogenic non-epileptic seizures, with and without comorbid epilepsy. Seizure 2006, 15:333-339.
138. Fiszman A., Kanner A.M. Comorbidities in psychogenic nonepileptic seizures: depressive, anxiety and personality disorders. Gates and Rowan's nonepileptic seizures 2010, 225-234. Cambridge University Press, Cambridge; New York. S.C. Schachter, W.C. LaFrance (Eds.).
139. Gilliam F. Optimizing health outcomes in active epilepsy. Neurology 2002, 58(8 Suppl. 5):S9-S20.
140. Dias R., Bateman L.M., Farias S.T., et al. Depression in epilepsy is associated with lack of seizure control. Epilepsy Behav 2010, 19(3):445-447.
141. Wyllie E., Friedman D., Rothner A.D., et al. Psychogenic seizures in children and adolescents: outcome after diagnosis by ictal video and electroencephalographic recording. Pediatrics 1990, 85(4):480-484.
142. Wyllie E., Glazer J.P., Benbadis S., Kotagal P., Wolgamuth B. Psychiatric features of children and adolescents with pseudoseizures. Arch Pediatr Adolesc Med 1999, 153(3):244-248.
143. Kramer U., Carmant L., Riviello J.J., et al. Psychogenic seizures: video telemetry observations in 27 patients. Pediatr Neurol 1995, 12(1):39-41.
144. Pakalnis A., Paolicchi J. Psychogenic seizures after head injury in children. J Child Neurol 2000, 15(2):78-80.
145. Kotagal P., Costa M., Wyllie E., Wolgamuth B. Paroxysmal nonepileptic events in children and adolescents. Pediatrics 2002, 110(4):1-5. e46.
146. Patel H., Scott E., Dunn D., Garg B. Nonepileptic seizures in children. Epilepsia 2007, 48(11):2086-2092.
147. Salpekar J.A., Plioplys S., Siddarth P., et al. Pediatric psychogenic nonepileptic seizures: a study of assessment tools. Epilepsy Behav 2010, 17(1):50-55.
148. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med 2002, 64(2):258-266.
149. Gilliam F.G., Barry J.J., Hermann B.P., Meador K.J., Vahle V., Kanner A.M. Rapid detection of major depression in epilepsy: a multicentre study. Lancet Neurol 2006, 5(5):399-405.
150. Derogatis L.R. Symptom Checklist 90-R: administration, scoring, and procedures manual 1994, National Computer Systems, Inc, Minneapolis MN. 3rd ed.
151. Beck A.T., Steer R.A., Brown G.K. Manual for the Beck Depression Inventory - Second Edition (BDI-II) 1996, Psychological Corporation, San Antonio.
152. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960, 23:56-62.
153. McNair D., Lorr M., Droppleman L. POMS: Profile of Mood States 1992, EITS/Educational and Industrial Testing Service, San Diego, CA.
154. Beck A.T., Steer R.A., Ball R., Ranieri W. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. J Pers Assess 1996, 67(3):588-597.
155. Lovibond P.F., Lovibond S.H. The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther 1995, 33(3):335-343.
156. Cramer J.A., Perrine K., Devinsky O., Meador K. A brief questionnaire to screen for quality of life in epilepsy: the QOLIE-10. Epilepsia 1996, 37(6):577-582.
157. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30(6):473-483.
158. Barge-Schaapveld D.Q., Nicolson N.A., Berkhof J., deVries M.W. Quality of life in depression: daily life determinants and variability. Psychiatry Res 1999, 88(3):173-189.
159. Breier J.I., Fuchs K.L., Brookshire B.L., et al. Quality of life perception in patients with intractable epilepsy or pseudoseizures. Arch Neurol 1998, 55(5):660-665.
160. Fargo J.D., Szaflarski J.P., Dulay M.F., Testa S.M., Schefft B.K. Abstract [P05.094] Relationship between subjective cognitive complaints and objective neuropsychological functioning in patients with epileptic (ES) or psychogenic nonepileptic seizures (PNES). Neurology 2003, 60(5 Supplement 1):A382.
161. Szaflarski J.P., Hughes C., Szaflarski M., et al. Quality of life in psychogenic nonepileptic seizures. Epilepsia 2003, 44(2):236-242.
162. Szaflarski J.P., Szaflarski M., Hughes C., Ficker D.M., Cahill W.T., Privitera M.D. Psychopathology and quality of life: psychogenic non-epileptic seizures versus epilepsy. Med Sci Monit 2003, 9(4):CR113-CR118.
163. Szaflarski J.P., Szaflarski M. Seizure disorders, depression, and health-related quality of life. Epilepsy Behav 2004, 5(1):50-57.
164. LaFrance W.C., Syc S. Depression and symptoms affect quality of life in psychogenic nonepileptic seizures. Neurology 2009, 73(5):366-371.
165. LaFrance W.C., Keitner G.I., Papandonatos G.D., et al. Pilot pharmacologic randomized controlled trial for psychogenic nonepileptic seizures. Neurology 2010, 75(13):1166-1173.
166. LaFrance W.C., Miller I.W., Ryan C.E., et al. Cognitive behavioral therapy for psychogenic nonepileptic seizures. Epilepsy Behav 2009, 14(4):591-596.
167. Goldstein L.H., Chalder T., Chigwedere C., et al. Cognitive-behavioral therapy for psychogenic nonepileptic seizures: a pilot RCT. Neurology 2010, 74(24):1986-1994.
168. Asmussen S.B., Kirlin K.A., Gale S.D., Chung S.S. Differences in self-reported depressive symptoms between patients with epileptic and psychogenic nonepileptic seizures. Seizure 2009, 18(8):564-566.
169. Baslet G., Roiko A., Prensky E. Heterogeneity in psychogenic nonepileptic seizures: understanding the role of psychiatric and neurological factors. Epilepsy Behav 2010, 17(2):236-241.
170. Bodde N.M., Bartelet D.C., Ploegmakers M., Lazeron R.H., Aldenkamp A.P., Boon P.A. MMPI-II personality profiles of patients with psychogenic nonepileptic seizures. Epilepsy Behav 2011, 20(4):674-680.
171. Bora I.H., Taskapilioglu O., Seferoglu M., et al. Sociodemographics, clinical features, and psychiatric comorbidities of patients with psychogenic nonepileptic seizures: experience at a specialized epilepsy center in Turkey. Seizure 2011, 20(6):458-461.
172. Grimaldi I., Dubuc M., Kahane P., Bougerol T., Vercueil L. Anxiety and depression in psychogenic movement disorder and non-epileptic seizures: a prospective comparative study. Rev Neurol (Paris) 2010, 166(5):515-522.
173. LaFrance W.C., Alosco M.L., Davis J.D. Impact of family functioning on quality of life in patients with psychogenic nonepileptic seizures versus epilepsy. Epilepsia 2011, 52(2):292-300.
174. Mazza M., Marca G.D., Martini A. Non-Epileptic Seizures (NES) are predicted by depressive and dissociative symptoms. Epilepsy Res 2009, 84:91-96.
175. Quigg M., Armstrong R.F., Farace E., Fountain N.B. Quality of life outcome is associated with cessation rather than reduction of psychogenic nonepileptic seizures. Epilepsy Behav 2002, 3(5):455-459.